Latest filing published 04 Jun 2022 for Avanza Bank AB, €13k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
AlphaHelix Molecular Diagnostics AB (publ): trading record in brief
This profile gathers the share dealings of AlphaHelix Molecular Diagnostics AB (publ) in Avanza Bank AB. We count 2 filings; the first trade dates from 17 May 2022 and the latest from 3 June 2022.
On the open market, the record shows 1 purchase worth €23k and 1 sale worth €13k. Netting one side against the other leaves €9,602 of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 4 June 2022, the filings show an open-market sale worth €13k in Avanza Bank AB. The latest purchase dates back some time: it was published 1,635 days ago, on 17 May 2022. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to AlphaHelix Molecular Diagnostics AB (publ)
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 127,525 shares@ SEK 1.0636.5% of flowAktieISIN SE0000885501FI:csv-04acccf16ced87199b0a
- 211,060 shares@ SEK 1.1263.5% of flowAktieISIN SE0000885501FI:csv-bd8002579a65aed2e850Canonical exit: 15 Aug 2022 (T+90)
2 of 2 declarations